Viralgen has partnered biotech company Trogenix, aiming to accelerate the development of gene therapy for glioblastoma.

BioVaxys Technology and Sona Nanotech have signed an agreement to develop cancer therapeutics, utilising the DPX platform ...

The Vivo Opportunity Fund has already catalysed a plethora of medicine development via biotech investments in its first two ...

ARS Pharmaceuticals has announced the availability of neffy (epinephrine nasal spray) 1mg in the United States.

At a time when investment has been low in biotech, establishing and maintaining good relationships with investors is vital.

This move comes a day after President Trump signed an executive order to streamline approval processes for domestic plants.

Venture philanthropy organisation Solve FSHD has announced an investment of $3m in Armatus Bio to support the development of ...

Discussing AstraZeneca’s experience with the Project Orbis pathway, Sabine Ledderhose, head of regulatory affairs for the ...

Novo Nordisk has cut its sales and profits forecasts for 2025 due to lower demand in the US for blockbuster weight loss and ...

The deal builds on an existing research collaboration between Eli Lilly and Alchemab to discover new ALS drugs.

Sarepta’s stock dropped by 26% after the FDA named a vocal critic of its gene therapy programme to lead its biologics ...

The European Commission (EC) has approved AstraZeneca's Bruton's tyrosine kinase (BTK) inhibitor Calquence (acalabrutinib) ...